BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
PBX1
,
cell-cell adhesion
,
HIV infection
,
Retina
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
claudin-2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Kidney cortex
Kidney
Duodenum
Kidney medulla
Small intestine
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Urolithiasis
Pancreatitis
Colitis
Inflammatory bowel disease
Sendai virus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
PTC-209
PCB 153
sunitinib
Ethionine
Serine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SPDEF
KMT2B
IRF5
FAT4
WDR77
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing…
SOX9 in Keratinocytes Regulates Claudin 2 Transcription during Skin Aging.
Maternal Epidermal Growth Factor Promotes Neonatal Claudin-2 Dependent Increases in Small Intestinal…
Xylobiose treatment strengthens intestinal barrier function by regulating claudin 2 and heat shock p…
AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction w…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis…
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advan…
TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ